Fimasartan (BR-A-657) Multiple Oral Dose in Healthy Subjects
- First Posted Date
- 2011-02-04
- Last Posted Date
- 2011-02-04
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 16
- Registration Number
- NCT01289899
A Clinical Study to Evaluate Efficacy and Safety of Fimasartan/Hydrochlorothiazide Combination-therapy
Phase 3
Completed
- Conditions
- Essential Hypertension
- Interventions
- Drug: Fimasartan/HCTZ combination
- First Posted Date
- 2010-12-13
- Last Posted Date
- 2012-01-05
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 263
- Registration Number
- NCT01258673
- Locations
- 🇰🇷
Seoul National University Hospital, Bundang, Sungnam, Korea, Republic of
Clinical Trial to Assess the Immunogenicity and Safety of the Vero Cell-derived JE Vaccine in Korea
Phase 3
Completed
- Conditions
- Japanese Encephalitis
- Interventions
- Biological: JE vaccine
- First Posted Date
- 2010-06-25
- Last Posted Date
- 2014-01-30
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 205
- Registration Number
- NCT01150942
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Renal Impairment Patients and Healthy Volunteers
- First Posted Date
- 2010-06-22
- Last Posted Date
- 2012-01-09
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 16
- Registration Number
- NCT01148368
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy Volunteers
- First Posted Date
- 2010-06-22
- Last Posted Date
- 2012-01-05
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 18
- Registration Number
- NCT01146938
- Locations
- 🇰🇷
Severance Hospital, Seoul, Korea, Republic of
The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension
Phase 3
Completed
- Conditions
- Hypertension
- Interventions
- First Posted Date
- 2010-06-02
- Last Posted Date
- 2012-08-24
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 290
- Registration Number
- NCT01135212
- Locations
- 🇰🇷
KyungPook National University Hospital, Daegu, Korea, Republic of
A Study to Assess Food Effect on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers
- First Posted Date
- 2009-11-04
- Last Posted Date
- 2009-12-24
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 24
- Registration Number
- NCT01007409
A Study to Evaluate the Effect of Fimasartan on Pharmacokinetics, and the Safety of Digoxin in Healthy Male Volunteers
Phase 1
Completed
- Conditions
- Essential Hypertension
- First Posted Date
- 2009-10-08
- Last Posted Date
- 2009-11-04
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 14
- Registration Number
- NCT00991783
A Study to Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers
- First Posted Date
- 2009-10-08
- Last Posted Date
- 2009-10-08
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 28
- Registration Number
- NCT00991705
Study to Compare and Assess the Safety and Pharmacokinetic Characteristics After Oral Administration of Fimasartan (BR-A-657∙K) in Healthy Elderly and Young Male Volunteers
- First Posted Date
- 2009-07-13
- Last Posted Date
- 2009-11-04
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 22
- Registration Number
- NCT00937534
© Copyright 2025. All Rights Reserved by MedPath